How Humanization Addresses Medicine’s Toughest Problems

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

Challenges and barriers in healthcare have been persistent for some time. Many would argue that what got left behind was compassion. However, new perspectives, technology, and collaboration are changing things. To discuss these topics, host Kevin Stevenson welcomed Dr. Summer Knight, author of Humanizing Healthcare and Managing Partner of Deloitte’s Life Sciences and Health Care practice.

“The system did help break one barrier with physicians from different health systems talking to one another.” –  Dr. Summer Knight

Dr. Knight has an impressive and diverse background. She began her career as a paramedic then became a physician. “I was practicing medicine, solving issues, and spending more time interacting with the state government,” she said.

Those interactions led her to become the Chief Medical Officer for the State of Florida. She then launched digital healthcare companies, realizing the importance of technology in the future of care. She also worked with Signa and Aetna.

Her goal now is to transform healthcare in a more humanized approach. “Patients are at the top of the pyramid, although we’re not really calling them this anymore. We call them clients because it elevates the respect,” Knight added.

Humanization is the way to solve big problems in a meaningful way. Her life and perspective changed when her son was diagnosed with cancer.

Through the experience, she built a strong support system and created a digital platform to share information from clinicians to family and friends. “The system did help break one barrier with physicians from different health systems talking to one another.”

That led her to write Humanizing Healthcare. In the book, she describes the trends changing healthcare: consumerism, technology, and regulatory. It focuses on cultural changes, removing barriers, and the delivery of care.

Knight and Stevenson also discussed the disruption of healthcare. While devastating, Knight does say there will be positive outcomes in the long run. “It’s forced adoption to virtual, and it’s been an accelerant for technology. It’s also forced interesting partnerships across silos and competitors.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More